Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines

Xiaoxia Guo, Bing Xu, Shuchita Pandey, Elisabeth Goessl, James Brown, Angel L. Armesilla, John L. Darling, Weiguang Wang

Research output: Contribution to journalArticle

Abstract

Most of the gemcitabine (dFdC) resistant cell lines manifested high NF?B activity. The NF?B activity can be induced by dFdC and 5-FU exposure. The chemosensitizing effect of disulfiram (DS), an anti-alcoholism drug and NF?B inhibitor, and copper (Cu) on the chemoresistant cell lines was examined. The DS/Cu complex significantly enhanced the cytotoxicity of dFdC (resistant cells: 12.2–1085-fold) and completely reversed the dFdC resistance in the resitant cell lines. The dFdC-induced NF?B activity was markedly inhibited by DS/Cu complex. The data from this study indicated that DS may be used in clinic to improve the therapeutic effect of dFdC in breast and colon cancer patients.
Original languageEnglish
Pages (from-to)104-113
Number of pages10
JournalCancer Letters
Volume290
Issue number1
Early online date25 Sep 2009
DOIs
Publication statusPublished - 1 Apr 2010

Fingerprint

gemcitabine
Disulfiram
Colonic Neoplasms
Copper
Breast Neoplasms
Cell Line
Therapeutic Uses
Fluorouracil
Alcoholism
Pharmaceutical Preparations

Keywords

  • NFκB
  • breast cancer
  • colorectal cancer
  • disulfiram
  • gemcitabine resistance

Cite this

Guo, Xiaoxia ; Xu, Bing ; Pandey, Shuchita ; Goessl, Elisabeth ; Brown, James ; Armesilla, Angel L. ; Darling, John L. ; Wang, Weiguang. / Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. In: Cancer Letters. 2010 ; Vol. 290, No. 1. pp. 104-113.
@article{dd42109bad7b4aac85a4fc9993c09b4a,
title = "Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines",
abstract = "Most of the gemcitabine (dFdC) resistant cell lines manifested high NF?B activity. The NF?B activity can be induced by dFdC and 5-FU exposure. The chemosensitizing effect of disulfiram (DS), an anti-alcoholism drug and NF?B inhibitor, and copper (Cu) on the chemoresistant cell lines was examined. The DS/Cu complex significantly enhanced the cytotoxicity of dFdC (resistant cells: 12.2–1085-fold) and completely reversed the dFdC resistance in the resitant cell lines. The dFdC-induced NF?B activity was markedly inhibited by DS/Cu complex. The data from this study indicated that DS may be used in clinic to improve the therapeutic effect of dFdC in breast and colon cancer patients.",
keywords = "NFκB, breast cancer, colorectal cancer, disulfiram, gemcitabine resistance",
author = "Xiaoxia Guo and Bing Xu and Shuchita Pandey and Elisabeth Goessl and James Brown and Armesilla, {Angel L.} and Darling, {John L.} and Weiguang Wang",
year = "2010",
month = "4",
day = "1",
doi = "10.1016/j.canlet.2009.09.002",
language = "English",
volume = "290",
pages = "104--113",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier",
number = "1",

}

Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. / Guo, Xiaoxia; Xu, Bing; Pandey, Shuchita; Goessl, Elisabeth; Brown, James; Armesilla, Angel L.; Darling, John L.; Wang, Weiguang.

In: Cancer Letters, Vol. 290, No. 1, 01.04.2010, p. 104-113.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines

AU - Guo, Xiaoxia

AU - Xu, Bing

AU - Pandey, Shuchita

AU - Goessl, Elisabeth

AU - Brown, James

AU - Armesilla, Angel L.

AU - Darling, John L.

AU - Wang, Weiguang

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Most of the gemcitabine (dFdC) resistant cell lines manifested high NF?B activity. The NF?B activity can be induced by dFdC and 5-FU exposure. The chemosensitizing effect of disulfiram (DS), an anti-alcoholism drug and NF?B inhibitor, and copper (Cu) on the chemoresistant cell lines was examined. The DS/Cu complex significantly enhanced the cytotoxicity of dFdC (resistant cells: 12.2–1085-fold) and completely reversed the dFdC resistance in the resitant cell lines. The dFdC-induced NF?B activity was markedly inhibited by DS/Cu complex. The data from this study indicated that DS may be used in clinic to improve the therapeutic effect of dFdC in breast and colon cancer patients.

AB - Most of the gemcitabine (dFdC) resistant cell lines manifested high NF?B activity. The NF?B activity can be induced by dFdC and 5-FU exposure. The chemosensitizing effect of disulfiram (DS), an anti-alcoholism drug and NF?B inhibitor, and copper (Cu) on the chemoresistant cell lines was examined. The DS/Cu complex significantly enhanced the cytotoxicity of dFdC (resistant cells: 12.2–1085-fold) and completely reversed the dFdC resistance in the resitant cell lines. The dFdC-induced NF?B activity was markedly inhibited by DS/Cu complex. The data from this study indicated that DS may be used in clinic to improve the therapeutic effect of dFdC in breast and colon cancer patients.

KW - NFκB

KW - breast cancer

KW - colorectal cancer

KW - disulfiram

KW - gemcitabine resistance

UR - http://www.scopus.com/inward/record.url?scp=77249117637&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.09.002

DO - 10.1016/j.canlet.2009.09.002

M3 - Article

VL - 290

SP - 104

EP - 113

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -